Standard approach and quality system for confocal enteroscopy
Official title: Standardized Implementation and Quality Assessment System for Confocal Enteroscopy
Run by Shanghai Jiao Tong University School of Medicine · NCT07363291 · Data updated 2026-11-12
This project will test whether using confocal laser endomicroscopy during balloon enteroscopy can improve diagnosis and help set quality standards for people with suspected small-bowel disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Shanghai Jiao Tong University School of Medicine Academic / other |
| Locations | 8 sites (Hefei, Anhui and 7 other locations) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | June 1, 2028 |
| Study ends | June 1, 2028 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT07363291 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 who are scheduled for small-bowel endoscopy to characterize suspected small-bowel disease (for example suspected Crohn's disease, unclassified IBD, hereditary small-bowel neoplasia syndromes, or suspected small-bowel lymphoma) are ideal candidates.
✕Probably not a fit
People who cannot tolerate complete endoscopy, have severe hepatic or renal failure, known hypersensitivity to required agents, are outside the age range, or are otherwise unable to undergo the procedure are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multi-center observational project will collect 200 confocal small-bowel enteroscopy cases and 400 gastrointestinal control cases split into exploratory and validation arms. During single- or double-balloon enteroscopy, areas of suspected lesions and adjacent normal mucosa will be examined with confocal laser endomicroscopy (CLE) alongside conventional enteroscopic assessment and histology. CLE features will include mucosal-barrier metrics, inflammatory and mucosal-healing scores, and will be analyzed with AI image-recognition tools to identify diagnostic patterns. The exploratory arm will derive candidate diagnostic parameters and quality metrics, which the validation arm will then test for reproducibility across centers and operators.
Why it matters
Potential benefit: If successful, this work could enable faster, more accurate small-bowel diagnoses and reduce unnecessary biopsies or delayed treatment by giving doctors clearer real-time cellular information and standardized quality procedures.
How similar studies have gone: Confocal laser endomicroscopy has demonstrated clinical value for upper and lower gastrointestinal lesions, but its application to small-bowel pathology is largely novel and less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18-70 years and scheduled to undergo small-bowel endoscopy. * Able to provide written informed consent and willing to participate in the study. * Certified gastroenterologists with an intermediate (or higher) professional title. Have completed formal training and passed competency assessments in gastroscopy, colonoscopy, and small-bowel endoscopy. -Willing to participate and able to provide written informed consent. Exclusion Criteria: * Poor general condition, severe hepatic or renal insufficiency, or inability to tolerate complete endoscopic examination. * Known hypersensitivity to any study-related agents (fluorescein sodium, polyethylene glycol, lidocaine mucilage). * Currently enrolled in another clinical trial. * Never perform endoscopic procedures. * Endoscopic procedure or image-reading volume \< 100 cases in the past 2 years. * Medical license revoked or currently suspended for any reason.
Where it's running
-
Renji Hospital Anhui Hospital
Hefei, Anhui, China Recruiting -
Ningbo Hangzhou Bay Hospital
Ningbo, Zhejiang, China Recruiting -
Kashgar Second People's Hospital
Kashgar, China Recruiting -
Huashan Hospital, Fudan University
Shanghai, China Recruiting -
Renji Hospital
Shanghai, China Recruiting -
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China Recruiting
Show 2 more locations
-
Shanghai Sixth People's Hospital
Shanghai, China Recruiting -
Zhongshan Hospital, Fudan University
Shanghai, China Recruiting
Study contacts
- Study coordinator: Xiaobo Li, MD. PhD
- Email: lxb_1969@163.com
- Phone: 13901631056
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FM Move: A New Method for Moving Back Teeth During Clear Aligner Therapy
A single-group study tests a new FM method to move the canine and first molar together in people needing back-teeth movement, to see if treatment time can be shortened.
-
Sitogilun Malate with Amlodipine in High Blood Pressure with Early Kidney Risk
This trial tests whether sitogilun malate plus amlodipine helps lower blood pressure in adults with mild-to-moderate hypertension and early signs of kidney stress.
-
Active safety and performance monitoring of a biodegradable PFO closure device and a transcatheter mitral valve repair system
This study tracks how well a biodegradable PFO closure device and a transcatheter mitral valve repair system work and stay safe when used in routine care.
-
AI-powered personalized exercise coaching for women with breast cancer
This trial tests whether an AI-driven, personalized exercise program helps women with breast cancer after treatment compared to standard exercise guidance.
-
Oral health, saliva bacteria, and disease activity in children with JIA
This study checks if how active juvenile idiopathic arthritis is relates to oral health in children who already receive rheumatology care.
-
Neoadjuvant Pyrotinib-to-pertuzumab for HER2-positive early breast cancer
This trial tests whether a two-step neoadjuvant plan with Pyrotinib plus Trastuzumab and Docetaxel followed by Pertuzumab plus Trastuzumab and Docetaxel works better than four cycles of Pertuzumab plus Trastuzumab and Docetaxel in women with HER2-positive early- to locally advanced breast cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.